October 28, 2026 Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets
October 28, 2026 Sinopec Releases Africa Sustainability Report and Launches WE17 Global Communication Brand in Cairo